Trofosfamide
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Also known as: ixoten, trifosfamide, trilofosfamida, trilophosphamide, triphosphamide, trisfosfamide, trofosfamid, trophosphamid, trophosphamide
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Trofosfamide is a drug catalogued in DrugCentral.
- ATC code: L01AA07 (Nitrogen mustard analogues).
- Molecular formula: C9H18Cl3N2O2P; molecular weight 323.59 g/mol.
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
L01AA07 | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS › ANTINEOPLASTIC AGENTS › ALKYLATING AGENTS › Nitrogen mustard analogues |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Rhabdomyosarcoma recurrent | 89.9 |
Chemical structure
| Molecular formula | C9H18Cl3N2O2P |
|---|---|
| Molecular weight | 323.59 g/mol |
| CAS number | — |
| InChIKey | UMKFEPPTGMDVMI-UHFFFAOYSA-N |
| PubChem CID | 65702 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is the chemical formula of Trofosfamide?
Trofosfamide has the molecular formula C9H18Cl3N2O2P and a molecular weight of 323.59 g/mol.
Browse: all drugs starting with T · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 2766 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL462019 — compound record and bioactivity
- PubChem CID 65702 — chemical identifiers
- DrugBank DB12902 — drug record
- FDA UNII H64JRU6GJ0 — substance identity
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.